View Document Preview and Link Document Date: 2014-03-03 08:45:38 Open Document File Size: 206,19 KB Share Result on Facebook
City Koc / Calgary / / Company European Bone Marrow Transplant Group / Osiris Therapeutics / THOMSON REUTERS / Ge / Fresenius / Kernan N.A. / MacMillan / / Country Canada / Columbia / / / Event FDA Phase / / Facility University of Calgary / / IndustryTerm treatment for steroid refractory graft-versushost disease / compassionate-use multicenter protocol / cancer treatment / cellular therapy product / therapy for Crohn’s disease / TREATMENT OF GRAFT-VERSUS-HOST DISEASE / gov Web site / / MedicalCondition relapsed acute lymphoblastic leukemia / better disease / Infectious complications / graft-versus-host disease / dysfunction / rash Maculopapular rash / tissue injury / nausea / severe aplastic anemia / body surface area Maculopapular rash / generalized bullous dermatitis / M. Recombinant human soluble tumor necrosis / severe infection / severe abdominal pain / diarrhea / inflammatory cascade / Bloody diarrhea / organ dysfunction / infections / leukemia / abdominal pain / cancer / disease / fatal viral infection / Chronic / host disease / E. Graft-versushost disease / Crohn’s disease / chronic illness / hematologic malignancies / µmol/L Diarrhea / severe diarrhea / ileus / mucositis / tumor necrosis / low-volume diarrhea / opportunistic infection / µmol/L No diarrhea Diarrhea / positive gastric biopsy Diarrhea / chronic myelogenous leukemia / infection / high-risk hematological malignancy / malignant osteopetrosis / inflammatory responses / localized skin rash / hematologic malignancy / / MedicalTreatment immunosuppressive therapies / Extracorporeal photochemotherapy / chemotherapy / radiotherapy / Bone Marrow Transplant / intravenous infusion / Extracorporeal photopheresis / immunosuppression / immunosuppressive therapy / bone marrow transplants / lymphocyte depletion / / Organization Medicines and Medical Devices Safety Authority / Center for International Blood and Marrow Transplant Research / Tom Baker Cancer Center / EBMT Chronic Leukemia Working Party / FDA / University of Calgary / Department of Oncology / International Society for Cellular Therapy / / Person Andrew Daly / Carmen Tarin-Arzaga / Van Lint / Prasad / V / Anders / V / Anasetti / Tom Baker / Weisdorf / / Position paid consultant / MP / Carpenter / D.J. / Fisher / L. et al / representative / Associate Professor / high-dose MP vs. high-dose MP / / Product methylprednisolone / Skullcandy G.I. Headphone/Headset / cyclosporine / pentostatin / Siemens S45 Cellular Phone / prograf / prednisone / dimethyl sulfoxide / World’s first approved stem cell drug / GVHD / CD3 / Prochymal / / ProvinceOrState Alberta / Maryland / South Carolina / O.N. / / PublishedMedium Osiris / / Technology alpha / antibodies / compassionate-use multicenter protocol / transplantation / stem cells / ATG / chemotherapy / / SocialTag 
Drugs of Today 2012, 48(12): [removed]THOMSON REUTERS Copyright © 2012 Prous Science, S.A.U. or its licensors. All rights reserved. CCC: [removed]